Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F
- 6 April 1992
- journal article
- Published by Wiley in FEBS Letters
- Vol. 300 (3) , 241-246
- https://doi.org/10.1016/0014-5793(92)80854-a
Abstract
The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, CTC----TTC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.Keywords
This publication has 31 references indexed in Scilit:
- A simple and rapid method of direct sequencing using DynabeadsBritish Journal of Haematology, 1991
- Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin IIIBiochemistry, 1990
- Antithrombin III: structural and functional aspectsBiochimie, 1990
- Antithrombin Rouen‐IV 24 Arg→Cys The amino‐terminal contribution to heparin bindingFEBS Letters, 1990
- Implications of the three-dimensional structure of .alpha.1-antitrypsin for structure and function of serpinsBiochemistry, 1989
- New carbohydrate site in mutant antithrombin (7 Ile→Asn) with decreased heparin affinityFEBS Letters, 1988
- Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.Journal of Clinical Investigation, 1988
- Physiological variant of antithrombin‐III lacks carbohydrate sidechain at Asn 135FEBS Letters, 1987
- Antithrombin III alger: A new case of Arg 47 ← cys mutationAmerican Journal of Hematology, 1987
- Anticoagulantly active heparin-like molecules from vascular tissueBiochemistry, 1984